These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7012070)

  • 1. [Benefits and dangers of adjuvant chemotherapy and radiotherapy for the prevention of metastases].
    Brunner KW
    Internist (Berl); 1981 Feb; 22(2):62-7. PubMed ID: 7012070
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uses and hazards of adjuvant chemotherapy and irradiation in the prevention of metastases].
    Brunner KW
    Verh Dtsch Ges Inn Med; 1980; 86():527-36. PubMed ID: 7223041
    [No Abstract]   [Full Text] [Related]  

  • 3. [Size distribution of metastases during detection and adjuvant treatment: biomathematical approach].
    Guiguet M; Tubiana M; Valleron AJ
    C R Seances Acad Sci III; 1982 Jan; 294(1):15-8. PubMed ID: 6804023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Massive cytostatic therapy after orthovoltage therapy].
    Schawow A
    Radiobiol Radiother (Berl); 1970; 11(6):655-9. PubMed ID: 5509232
    [No Abstract]   [Full Text] [Related]  

  • 5. [A contribution on the study of radioactive drugs].
    Mitchell JS
    Strahlentherapie; 1966 Nov; 131(3):331-41. PubMed ID: 6011869
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neoadjuvant and adjuvant therapies for solid tumours].
    Heinemann V; Moosmann N
    MMW Fortschr Med; 2007 Sep; 149(35-36):27-30. PubMed ID: 17944281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined radiotherapy and chemotherapy of malignant tumors].
    Rodé I
    Radiobiol Radiother (Berl); 1970; 11(4):345-8. PubMed ID: 5508941
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
    Curtin JP; Shapiro F
    Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH
    Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis.
    Gligorov J; Pritchard K; Goss P
    Breast; 2007 Dec; 16 Suppl 3():S1-9. PubMed ID: 18061455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy in Hodgkin disease: why risk a Pyrrhic victory?
    Longo DL
    J Natl Cancer Inst; 2005 Oct; 97(19):1394-5. PubMed ID: 16204683
    [No Abstract]   [Full Text] [Related]  

  • 12. Hodgkin's disease after ovarian dysgerminoma.
    Bandini G; Visani G; Baccarani M
    Haematologica; 1981 Apr; 66(2):252. PubMed ID: 6792004
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrated preoperative radiotherapy.
    McCredie JA; Inch WR; Watson TA
    Rev Surg; 1968; 25(2):80-6. PubMed ID: 5655697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thyroid cancer occurring 15 years after the cure of Hodgkin's disease treated by cervical irradiation, then chemotherapy].
    Najean Y; Messian O
    Nouv Presse Med; 1982 Oct; 11(38):2851-2. PubMed ID: 7177823
    [No Abstract]   [Full Text] [Related]  

  • 16. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F; Rubino C; Guerin S; Diallo I; Samand A; Hawkins M; Oberlin O; Lefkopoulos D; De Vathaire F
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):908-15. PubMed ID: 18262102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation prevention of recurrences and metastases of malignant tumors].
    Ruderman AI
    Vopr Onkol; 1969; 15(10):15-20. PubMed ID: 5372746
    [No Abstract]   [Full Text] [Related]  

  • 19. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.